Get the Stockscreener App
34.51
0.76%
-0.265
After Hours:
34.51
0.005
+0.01%
Atricure Inc stock is traded at $34.51, with a volume of 671.83K.
It is down -0.76% in the last 24 hours and up +19.81% over the past month.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
See More
Previous Close:
$34.77
Open:
$34.21
24h Volume:
671.83K
Relative Volume:
0.74
Market Cap:
$1.75B
Revenue:
$534.53M
Net Income/Loss:
$-11.45M
P/E Ratio:
-143.11
EPS:
-0.2411
Net Cash Flow:
$48.28M
1W Performance:
+0.54%
1M Performance:
+19.81%
6M Performance:
-12.13%
1Y Performance:
+18.01%
1-Day Range:
$33.90
$34.94
1-Week Range:
$33.72
$36.33
52-Week Range:
$25.36
$43.18
Atricure Inc Stock (ATRC) Company Profile
Name
Atricure Inc
Sector
Industry
Phone
513-755-4100
Address
7555 INNOVATION WAY, MASON, OH
Compare ATRC vs ISRG, BDX, MDLN, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
34.51 | 1.76B | 534.53M | -11.45M | 48.28M | -0.2411 |
ISRG
Intuitive Surgical Inc
|
350.06 | 125.08B | 11.03B | 3.16B | 2.83B | 8.7254 |
BDX
Becton Dickinson Co
|
153.84 | 42.57B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
39.09 | 32.88B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.35 | 34.16B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
195.80 | 28.81B | 5.54B | 1.52B | 1.74B | 10.37 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-18-26 | Downgrade | Oppenheimer | Outperform → Perform |
| Feb-11-26 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-17-24 | Resumed | JP Morgan | Overweight |
| Apr-23-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Oct-23-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-29-23 | Initiated | UBS | Buy |
| Aug-05-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Dec-18-20 | Reiterated | Needham | Buy |
| Nov-06-20 | Reiterated | Needham | Buy |
| Apr-07-20 | Initiated | Oppenheimer | Outperform |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jan-24-20 | Reiterated | Needham | Buy |
| Aug-13-19 | Downgrade | Northland Capital | Outperform → Market Perform |
| Apr-12-19 | Initiated | JP Morgan | Overweight |
| Oct-04-18 | Reiterated | Needham | Buy |
| Aug-02-18 | Reiterated | Needham | Buy |
| Aug-02-18 | Reiterated | Stifel | Buy |
| Jun-18-18 | Reiterated | Needham | Buy |
| Apr-27-18 | Reiterated | Needham | Buy |
| Jan-16-18 | Reiterated | Needham | Buy |
| Nov-02-17 | Reiterated | Needham | Buy |
| Jul-28-17 | Reiterated | Needham | Buy |
| May-30-17 | Resumed | Piper Jaffray | Overweight |
| Jun-30-16 | Resumed | JMP Securities | Mkt Outperform |
| Oct-28-15 | Reiterated | Needham | Buy |
| Oct-06-15 | Reiterated | Canaccord Genuity | Buy |
| Oct-06-15 | Reiterated | Needham | Buy |
View All
Atricure Inc Stock (ATRC) Latest News
Citizens reiterates AtriCure stock rating on product growth outlook - Investing.com
AtriCure (ATRC) Proxy filing Summary - Quartr
(ATRC) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Needham Initiates AtriCure(ATRC.US) With Buy Rating, Announces Target Price $45 - Moomoo
Needham Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $45 - Moomoo
AtriCure (ATRC) Investor Day 2025 Summary - Quartr
Is AtriCure's (ATRC) Russell 2000 Defensive Debut Quietly Reframing Its Risk‑Reward Profile? - simplywall.st
AtriCure (ATRC) Jumps Nearly 7% as Healthcare Sector Sees Renewed InterestTotal Put Call - dars.gov.et
AtriCure to announce second quarter 2026 financial results - scanx.trade
AtriCure to Announce Second Quarter 2026 Financial Results - BioSpace
Form 4 AtriCure Inc For: 2 July By Investing.com - Investing.com Canada
AtriCure (ATRC) CEO adds 636 shares through 2018 Employee Stock Purchase Plan - Stock Titan
AtriCure, Inc. (ATRC) CSO acquires 636 ESPP shares at discount - Stock Titan
AtriCure (ATRC) CLO acquires 636 shares in ESPP purchase - Stock Titan
AtriCure (ATRC) COO adds ESPP shares in routine acquisition - Stock Titan
AtriCure (ATRC) CTO adds shares through discounted Employee Stock Purchase Plan - Stock Titan
AtriCure | 4: Statement of changes in beneficial ownership of securities-Officer Privitera Salvatore - Moomoo
Press Release: AtriCure to Announce Second Quarter 2026 Financial Results - Moomoo
GRANDEUR PEAK GLOBAL MICROCAP FUND's AtriCure Inc(ATRC) Holding History - GuruFocus
Enterprise value to revenue forward of AtriCure, Inc. – NASDAQ:ATRC - TradingView
Price to book forward of AtriCure, Inc. – NASDAQ:ATRC - TradingView
Price to sales forward of AtriCure, Inc. – NASDAQ:ATRC - TradingView
Canaccord reiterates AtriCure stock Buy rating after FDA clearance - Investing.com UK
Canaccord reiterates AtriCure stock Buy rating after FDA clearance By Investing.com - Investing.com Nigeria
CCORF Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $55 - Moomoo
AtriCure (ATRC) Q2 2025 earnings summary - Quartr
AtriCure (ATRC) Joins Multiple Russell 2000 Defensive Indexes Is Its Risk Profile Evolving? - simplywall.st
Edwards wins FDA clearance for LAA clip, setting up competition with AtriCure and Medtronic - MedTech Dive
AtriCure, Inc.(NasdaqGM: ATRC) added to Russell 2000 Defensive Index - marketscreener.com
AtriCure, Inc. Actuals & Estimates (NASDAQ:ATRC) - TradingView
AtriCure, Inc. Actuals & Estimates (DUS:A5I) - TradingView
ATRC Forecast — Price Target — Prediction for 2027 - TradingView
How (ATRC) Movements Inform Risk Allocation Models - Stock Traders Daily
AtriCure stock trades up with limited momentum as technical resistance remains - Traders Union
AtriCure Inc (ATRC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
ATRC PE Ratio & Valuation, Is ATRC Overvalued - Intellectia AI
AtriCure stock jumps 6.19% as streamlined ablation integration takes spotlight, AtriCure reports - Traders Union
AtriCure (ATRC) Soars 6.2%: Is Further Upside Left in the Stock? - Yahoo Finance
AtriCure Inc (ATRC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
AtriCure Inc (ATRC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AtriCure Inc (ATRC) Institutional Confidence - TradingKey
AtriCure Inc (ATRC) Valuation: PE, PB & Fair Value Analysis - TradingKey
AtriCure Inc (ATRC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
AtriCure Inc (ATRC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
AtriCure Inc (ATRC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
AtriCure Inc (ATRC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
AtriCure (ATRC) Holds Steady at $27.98: Consolidation Near Key Resistance LevelsHead and Shoulders - DonanımHaber
AtriCure (ATRC) Declines 2.8% as Shares Approach Critical Support at $26.58Sweep Order Flow - DonanımHaber
Trading Systems Reacting to (ATRC) Volatility - Stock Traders Daily
Do options traders know something about AtriCure stock we don't? - MSN
AtriCure (ATRC) Q1 2026 Earnings Transcript - AOL.com
Atricure Inc Stock (ATRC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.63%
0.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):